Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (211-220 of 299) with videos related to

Pageof 30
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2007
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphomaMichael J Robertson, Brad S Kahl, Julie M Vose, et al.
British Journal of Haematology|September 12, 2015
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphomaKoichi Takahashi, Mariela Sivina, Julia Hoellenriegel, et al.
The American Journal of Surgical Pathology|July 3, 2015
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression ProfilingJi Yuan, George Wright, Andreas Rosenwald, et al.
Blood|July 29, 2004
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant RegistryCésar O Freytes, Fausto R Loberiza, J Douglas Rizzo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
NCCN clinical practice guidelines in oncology: multiple myelomaKenneth C Anderson, Melissa Alsina, William Bensinger, et al.
Blood|May 14, 2011
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma projectJan Delabie, Harald Holte, Julie M Vose, et al.
Blood|August 2, 2003
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphomaKoen van Besien, Fausto R Loberiza, Ruta Bajorunaite, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysisAndrew M Evens, Ranjana Advani, Oliver W Press, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioningParameswaran Hari, Jeanette Carreras, Mei-Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy studyPier Paolo Piccaluga, Fabio Fuligni, Antonio De Leo, et al.
Pageof 30

Showing results (211-220 of 299) with videos related to

Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2007
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphomaMichael J Robertson, Brad S Kahl, Julie M Vose, et al.
British Journal of Haematology|September 12, 2015
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphomaKoichi Takahashi, Mariela Sivina, Julia Hoellenriegel, et al.
The American Journal of Surgical Pathology|July 3, 2015
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression ProfilingJi Yuan, George Wright, Andreas Rosenwald, et al.
Blood|July 29, 2004
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant RegistryCésar O Freytes, Fausto R Loberiza, J Douglas Rizzo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
NCCN clinical practice guidelines in oncology: multiple myelomaKenneth C Anderson, Melissa Alsina, William Bensinger, et al.
Blood|May 14, 2011
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma projectJan Delabie, Harald Holte, Julie M Vose, et al.
Blood|August 2, 2003
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphomaKoen van Besien, Fausto R Loberiza, Ruta Bajorunaite, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysisAndrew M Evens, Ranjana Advani, Oliver W Press, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioningParameswaran Hari, Jeanette Carreras, Mei-Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy studyPier Paolo Piccaluga, Fabio Fuligni, Antonio De Leo, et al.
Pageof 30